Global X - S&P Biotech ETF EBIT

See how CURE.AX's EBIT trends over time vs similar companies.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

N/A

Annual EBIT (TTM)

N/A

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin

Global X - S&P Biotech ETF (CURE.AX) FAQ

Stockcircle tracks ebit for Global X - S&P Biotech ETF (CURE.AX), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This EBIT page is built for Global X - S&P Biotech ETF's historical EBIT trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use EBIT as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main CURE.AX overview so you can move from this figure to the surrounding analysis quickly.